Getah virus (GETV) is a member of the genus Alphavirus in the family Togaviridae. GETV infection can occur in a wide range of vertebrate species, and the virus has been known for a pathogen of horses and pigs. To rapidly and accurately diagnose GETV infection of a racehorse, an indirect ELISA (I-ELISA) was developed in the present study for detection of antibodies to GETV in serum samples. To evaluate the developed I-ELISA, a total of 240 serum samples from Thoroughbred racehorses raised in Korea were screened in parallel by a serum neutralization (SN) test. The developed I-ELISA exhibited an efficacy comparable to that of the SN test in terms of a high diagnostic sensitivity (86.3%) and specificity (94.5%) at a cut-off absorbance value of 0.25. In addition, our results showed that the developed I-ELISA had a significant correlation with the SN test (r = 0.91; p < 0.05). Taken together, our findings suggest that the I-ELISA developed in this study is a valuable diagnostic tool for the screening of horses suspected to be infected with GETV.
INTRODUCTION

Getah virus (GETV) is a member of the genus
GETV infection has been identified in numerous vertebrate species (8) . GETV is maintained in nature by zoonotic transmission cycles involving nonhuman primate/vertebrate hosts and primary arthropod vectors (9) . In these cycles, horses and pigs are amplifying hosts for GETV (10) .
Although horse-to-horse transmission is possible, mosquitoes (mainly Culex and Aedes species) are the most important arthropod vectors for GETV transmission to host animals (10~12). The GETV has been known for a pathogen of horses and pigs. The infection is associated with sporadic outbreaks of a mild febrile illness in horses, though it can also cause miscarriage in sow and death in newborn piglets (13, 14) . Clinical symptoms in horse include fever, hindlimb edema and stiffness, but the disease is not lifethreatening (15, 16) . In addition, these clinical symptoms 63 resemble other infectious and noninfectious diseases, including equine viral arteritis, equine rhinopneumontis, equine encephalosis, equine influenza, equine infectious anemia, African horse sickness fever, purpura haemorrhagica and hoary alyssum toxicosis (17) . Therefore, rapid and accurate diagnosis of GETV infection must be confirmed through laboratory examinations.
Previous serosurveillance studies reported large numbers of horses in endemic areas to be seropositive, despite the rarity of clinical symptoms associated with GETV infection.
In Japan, 3~5% of horses have antibodies against GETV; the highest rate of seropositivity (93%) was found in older horses in northern Japan (15, 18, 19) . In other countries, rates of seropositivity for GETV in horses have been reported to be 17% in India and 25% in Hong Kong (20, 21) . In Korea, the first serosurveillance study of GETV was performed in 1987 from a total of 464 Thoroughbred racehorses (22) .
This study demonstrated that the rates of seropositivity for GETV in racehorses were 34%. According to the recent serosurveillance studies, the rates of seropositivity for GETV in racehorses were 12.4% and 12.2% in 2013 and 2014, respectively (22) , significantly lower than that reported in 1987. These data suggest that due to an aggressive mosquito eradication program, the incidence of GETV infection has been decreased gradually, but the prevalence of viral infection in horses is likely to stay constant over the past two years in Korea.
Routine laboratory diagnosis of GETV infection is based on virus cultures and serology, followed by detection of the viral genome by reverse transcription-polymerase chain reaction (23, 24) . However, these processes are timeconsuming and labor-intensive, and the degree of success is dependent on a number of complicating factors (25) . In general, rapid and specific detection is critical for the intensive surveillance of a viral disease. Serological assays such as hemagglutination inhibition and serum neutralization (SN) tests are considered the most specific methods for differentiating GETV from other antigenically related alphaviruses (12, 24, 26) . ELISA is also considered to be a specific and sensitive method of detecting serum antibodies against GETV, equivalent to serological assays (27) .
In the present study, we describe the development and evaluation of an indirect ELISA (I-ELISA) method for GETV antibodies and compare its specificity and sensitivity with those of the SN test.
MATERIALS AND METHODS
Serum samples, viruses and cells
The 240 serum samples analyzed in this study were 
Serum virus neutralization test
Neutralizing antibodies to GETV were detected and quantified in 240 horse serum samples by using serum virus neutralization test (SN). SN tests were carried out in 96-well cell culture plates as described previously (29 
Preparation of GETV antigen
Viruses were concentrated as described previously (30, 31) . The viral suspensions were filtered using membrane filters of 0.2 μm pore size to remove unwanted cell debris and to produce clarified samples for further downstream purification. In brief, the pre-chilled viral suspension was subjected to precipitation using 10% (w/v) Polyethylene glycol 8000 (PEG 8000; Sigma-Aldrich) in the presence of 0.5 M (w/v) NaCl. The mixture was centrifuged at 2,000 × g for 10 min following overnight incubation at 4℃. The PEG-concentrated pellets were dissolved in GTNE buffer (200 mM glycine, 100 mM Tris-Cl, 100 mM NaCl and 1 mM EDTA, pH 7.6). The viruses were purified by discontinuous sucrose gradient centrifugation in ultracentrifuge.
For this procedure, 20~60% (wt/wt) sucrose solution were prepared using GTNE buffer. The resuspended viruses were layered on the top of the 20% sucrose solution and centrifuged at 100,000 × g for 2 h. The clear band was collected carefully, and dialyzed against PBS to remove residual sucrose solution. Finally, the virus preparations were ultrafiltrated using Amicon ultracentrifugal filters (100 kDa) to increase the concentration of viruses in the sample, and then stored at -70℃ until use. The protein concentration was determined using a bicinchoninic protein assay kit (Pierce, Rockford, IL, USA).
Indirect ELISA
The optimum working concentrations of GETV antigen and serum for the I-ELISA were determined by the checkerboard titration method as described previously (29) . In brief, 50 μl of the GETV antigen, in an appropriate dilution ranging 
Statistical analysis
The correlation coefficients (r value) between the I-ELISA and SN tests were calculated using the linear regression program of GraphPad Prism version 4.0 (GraphPad Software Inc., San Diego, CA, USA), A p value < 0.05 was considered to indicate statistical significance.
RESULTS
Viral production
The optimal time for antigen harvest was determined based on the growth kinetics of GETV (Fig. 1A) . Confluent ref농rence sera. These GETV-Positive and -Negative reference sεra (P이 sera) were used for checkerboard titration.
Development and optimization of I-ELISA I-ELlSA based on purified wholε GETVantigεn was devεlopεd for detεction of GETV antibodies in sεrum samples from Thoroughbred racehorses. Optimum conditions for the I-ELISA were determined arbitrarily by means of checkerboard titration using the GETV-P!N sera (Fig. 2) . The positive reference sera showed hi양1 absorbance values when cells were coated with 5 or 2.5 μg viral antigen. Therefore, 2.5 μg GETV antigen was used in subsequent experiments.
The maximum difference between GETV-P!N sera was εvidεnt at a 1 :40 dilution; therefore, this dilution was us떠 m subsequent experiments. In addition, the maximum dilution of HRP-conjugated anti-horse IgG and the optimal reaction time were 1 :4,000 뻐d 1 h, respectively. In this test, a total of 150 serum samples that were negative according to the SN test (SN titer of < 1 :2) showed low reactivity to GETV antigεn in thε ELlSA. Thεse sera had an avεragε absorbancε of 0.17 with a standard dεviation of 0.0392. Thεrεforε， wε set an absorbance value of 0.25 as the threshold (cut-off value) for the I-ELISA (hoηzontalline in Fig. 2) . The most suitable blocking buffer for the T-ELTSA was 5% skim milk in PBS (data not shown).
Comparison of the I-ELISA and SN test
To evaluate its diagnostic reliability, the I-ELISA was compared with the SN test using a total of 240 horse serum 
DISCUSSION
I-ELISA was developed to replace serological assays as a routine method for detection of GETV antibodies, because I-ELISA has several advantages, principally simplicity and rapidity. In the present study, we developed an I-ELISA for GETV antibodies in horse serum using purified whole GETV antigen. Viral antigens were prepared from Vero cell cultures infected with GETV. To maximize the GETV antigen yield, the optimal time point for harvesting the virus was evaluated by analyzing the GETV growth kinetics (Fig. 1A) . For this purpose, infectious viral titers were determined in culture supernatants collected at various time points post-infection.
The maximum viral yield occurred between 36 and 48 hpi (10 7.5 TCID 50 /ml); viral production decreased gradually thereafter. The GETV-specific CPE appeared at ~18 hpi (data not shown), and most of the cells showed cytopathic changes accompanying cell detachment at 48 hpi. Therefore, the cessation of viral production coincided with the maximum GETV-specific CPE. Therefore, GETV antigens were harvested between 36 and 48 hpi.
The diagnostic accuracy of the I-ELISA in terms of its sensitivity and specificity in comparison with those of the SN test was compared using a two-sided contingency bodies against the bovine respiratory syncytial virus suggested a similar phenomenon (32) .
The most important aspect of ELISA development is the antigen used, as this has a marked effect on the performance of the test (33) . The whole GETV antigen used in this study was concentrated using PEG 8000 and purified by discontinuous sucrose gradient centrifugation. These methods resulted in a high yield of whole antigens with reduced nonspecific activity. This simple process will facilitate largescale production of whole GETV antigens.
In conclusion, this study describes the development of an I-ELISA for the rapid diagnosis of GETV infection in horses.
The performance of the I-ELISA was evaluated in comparison with the SN test using a total of 240 horse serum samples. The high sensitivity and specificity of the I-ELISA suggested its potential for screening of horses suspected to be infected with GETV. The whole GETV antigen used for the I-ELISA was prepared by PEG precipitation and discontinuous sucrose gradient centrifugation of GETV antigen.
This method enables whole GETV antigen preparation and development of I-ELISAs. Moreover, the I-ELISA developed in this study is economical due to the simple and rapid antigen preparation process.
